Summary of Key Points Core Viewpoint The Hong Kong Stock Exchange (HKEX) has seen significant activity in new listings and IPO applications, with notable performances from newly listed companies and ongoing interest from various sectors. Group 1: New Listings - On October 10, HKEX had two companies listed: ZhiDa Technology and JinYe International Group, with ZhiDa Technology closing up 192.14% at HKD 195.50 per share, giving it a market capitalization of approximately HKD 11.7 billion [3] - JinYe International Group saw a remarkable first-day increase of 330.00%, closing at HKD 2.15 per share, with a total market value of around HKD 860 million [3] Group 2: Ongoing IPO Applications - As of October 10, there are three companies currently undergoing the IPO process, with one completing its offering on the same day [4] - The companies include XuanZhu Bio-B, YunJi, and HaiXi New Drug, focusing on biopharmaceuticals and AI-enabled robotics [4] Group 3: Recent IPO Applications - From September 29 to October 10, a total of 35 companies submitted applications for listing on the main board of HKEX [8] - Notable applicants include: - LanNa Cheng, a clinical-stage biotech company focused on radiopharmaceuticals for cancer treatment [15] - JiMi Technology, a leading global brand in the projection industry [17] - WeiYi Holdings, a top player in China's digital health services market [21] - PuYuan Precision, the largest electronic measurement instrument supplier in China [23] - HuanChuang Technology, a leader in high-precision spatial perception solutions [26] - JingCun Technology, an independent manufacturer of embedded storage products [28] - MaiKeAoTe, a platform biotech company with core products in clinical trials [31] - JingShi Measurement and Control, focusing on flexible manufacturing solutions [33] - LuoShi Robotics, dedicated to the design and commercialization of intelligent robots [35] - ChangChun High-tech, a major player in the Chinese pharmaceutical industry [37] - JuXin Microelectronics, specializing in intelligent sensing and machine vision solutions [40] - BeiDa Pharmaceutical, a successful biopharmaceutical company in China [42] - LiOu Group, focusing on AI-driven digital marketing and smart systems [45] - Natural Hall, the third-largest domestic cosmetics group in China [47] - MiLian Technology, an online emotional social platform [50] - JingHe Integration, a global 12-inch pure wafer foundry [52] Group 4: Financial Performance - ZhiDa Technology's total market capitalization reached approximately HKD 11.7 billion on its first day [3] - JinYe International Group's market value was around HKD 860 million after its debut [3] - Financial data for various companies applying for IPOs indicates a mix of revenues and losses, with some companies like WeiYi Holdings projecting significant revenue growth from HKD 13.68 billion in 2022 to HKD 54.96 billion in 2024 [21] - Other companies like JingCun Technology expect revenue growth from HKD 20.96 billion in 2022 to HKD 37.14 billion in 2024 [28] Group 5: Risk Factors - Companies have disclosed various risk factors in their IPO applications, including reliance on successful drug approvals, competition, and market demand fluctuations [16][19][22][24][27][36][41][43][46]

9月29日，普源精电科技股份有限公司(以下简称"普源精电")在港交所提交上市申请，公司上市材料被正式受理，独家保荐人为中信证券。 资料显示，普源精电2022年4月登陆上交所，主营业务为通用电子测量仪器的研发、生产和销售。 据招股书，普源精电是中国领先的电子测量仪器公司，拥有先进的技术实力和遍布全球的庞大版图。根据弗若斯特沙利文的资料，公司是中国最大的电子 测量仪器供货商，按收益计，于2024年在全球排名第八。 财务数据方面，2022年至2024年，普源精电分别实现收入6.31亿元、6.71亿元、7.76亿元，净利润分别为9248.84万元、1.08亿元、9230.31万元，2024年净 利润有所下滑。 有机会获商报君送出的礼品 朋友们千万别错过！ ↓↓↓ 公司毛利率近年来一路提升，由2022年的50.9%升至2024年的54.9%，不过2025年上半年降至51.9%，显示公司盈利能力存在一定压力。 公司的原材料包括IC芯片、电子元件、结构件、印刷电路板、显示器等辅助材料。2022年至2024年及2025年上半年，原材料成本分别占销售成本的 73.9%、72.3%、67.8%及69.0%。普源精电坦言，原材料价 ...

Core Viewpoint - The financial data and operational status disclosed in the prospectus of Puyuan Precision Electric highlight a 14.6% decline in net profit and a 30.5% R&D investment ratio, indicating both challenges and opportunities for the company [1]. Business and Financial Status - Puyuan Precision Electric focuses on the electronic measurement instrument sector, offering a wide range of products including digital oscilloscopes and microwave RF instruments, serving over 100,000 end customers across more than 90 countries and regions, and covering multiple fields such as communication and new energy [2]. - The company emphasizes original technological innovation and has established a self-developed core technology platform, utilizing a combination of distributor sales and direct sales models [2]. Revenue and Profitability - Revenue has shown steady growth, driven by diverse product channels, while net profit has experienced a decline [3]. - Profitability is affected by significant cost and expense impacts, with gross margin fluctuations primarily driven by cost factors [3]. - Net profit margin varies with profitability fluctuations, influenced by multiple factors [3]. Risks and Challenges - Potential risks from related party transactions exist, as the company occasionally engages in transactions with related parties, which may raise questions about the fairness of transaction prices and the impact of changes in related party relationships on business [3]. - The absence of detailed industry comparisons in the prospectus makes it difficult to assess the company's competitive position, although its revenue and net profit growth suggest a certain level of market competitiveness [4]. - Continuous increases in R&D investment and cost pressures are challenges that the industry as a whole faces, necessitating further attention to the company's comparative advantages in technological innovation and cost control [4]. Customer and Supplier Risks - Customer concentration risk exists, with specific customers contributing over 10% of total revenue; for instance, Customer A generated 79.193 million yuan in 2024, and Customer B contributed 40.953 million yuan in the first half of 2025 [5]. - While customer concentration is relatively low, the loss or reduction of orders from major customers could still impact revenue [5]. - The prospectus lacks information on major suppliers and supplier concentration, making it difficult to assess the company's dependency on suppliers and potential risks such as supply interruptions or price fluctuations [6]. Corporate Governance and Management - The controlling shareholder, Dr. Wang Yue, holds approximately 61.01% of the voting rights, which may lead to significant influence over company decisions, posing risks if decisions are made incorrectly [7]. - The management team is experienced, but the effectiveness of their incentives remains to be observed [8]. - The company faces multiple risks, including declining net profit, increased R&D investment, cost and debt pressures, and various risk factors that could challenge future development [8].

普源精电已向香港交易所主板提交上市申请，中信证券为其独家保荐人。 根据弗若斯特沙利文的数据，普源精电是中国最大的电子测量仪器供应商，按2024年收益计，全球排名 第八。 公司在数字示波器和波形发生器领域处于领先地位，是中国最大的数字示波器供应商(全球第五)和波形 发生器供应商(全球第三)。 普源精电是中国第一家成功商用化搭载自研专用集成电路(ASIC)的数字示波器的公司。全球测试测量仪 器及解决方案市场规模预计将持续增长，2029年将达到约1700亿元人民币。 公司通过"RIGOL"品牌为90多个国家及地区的超过100000名终端客户提供服务，解决通信、新能源、半 导体、教育与科研领域的测试挑战。 ...

据港交所9月29日披露，普源精电科技股份有限公司(简称：普源精电(688337.SH))向港交所主板提交上市申请 书，中信证券为独家保荐人。 招股书显示，公司是电子测量仪器公司，拥有先进的技术实力和遍佈全球的庞大版图。根据弗若斯特沙利文的 资料，公司是中国最大的电子测量仪器供应商，按收益计，于2024年在全球排名第八。公司设计、开发、制造 并交付全面电子测量仪器及解决方案，助力科学探索与行业创新。公司通过"RIGOL"品牌，为90多个国家及地 区超过100,000名终端客户提供服务，解决各行各业客户在通信、新能源、半导体及教育与科研领域中的复杂测 试挑战。 公司经过多年专注研究开发("R&D")及创新，已建立以两大支柱为基础的全面电子测量组合：(i)以核心技术驱动 的产品矩阵，涵盖数字示波器、微波射频("RF")仪器、直流("DC")精密仪器及模块化仪器；(ii)多场景解决方案 套件，主要服务通信、新能源、半导体、教育与科研等高增长行业。根据弗若斯特沙利文的资料： 按2024年收 益计，公司是中国最大的数字示波器供应商，在全球排名第五；同时，公司是中国最大的波形发生器供应商， 在全球排名第三。公司亦是中国第一 ...

智通财经APP获悉，据港交所9月29日披露，普源精电科技股份有限公司(简称：普源精电(688337.SH))向港交所 主板提交上市申请书，中信证券为独家保荐人。 财务方面，于2022年度、2023年度、2024年度、2024年及2025年截至6月30日止六个月，普源精电实现收益分别 为约6.31亿元、6.71亿元、7.76亿元、3.07亿元、3.55亿元人民币；同期，年/期内利润分别为9248.8万元、约1.08 亿元、9230.3万元、1506.3万元、1621.6万元人民币。 | | | 截至12月31日止年度 | | 截至6月30日止六個月 | | | --- | --- | --- | --- | --- | --- | | | 2022年 | 2023年 | 2024年 | 2024年 | 2025年 | | | | | (人民幣千元) | | | | | | | | (未經濟計) | | | 收益 ... | 630.571 | 670.538 | 775.826 | 307.140 | 354.968 | | 銷售成本 | (309,417) | (312,252) | (349,868) | ...

智通财经APP获悉，据港交所9月29日披露，普源精电科技股份有限公司(简称：普源精电(688337.SH))向港交所 主板提交上市申请书，中信证券为独家保荐人。 | | | 截至12月31日止年度 | | 截至6月30日止六個月 | | | --- | --- | --- | --- | --- | --- | | | 2022年 | 2023年 | 2024年 | 2024年 | 2025年 | | | | | (人民幣千元) | | | | | | | | (未經濟計) | | | 收益 ... | 630.571 | 670.538 | 775.826 | 307.140 | 354.968 | | 銷售成本 | (309,417) | (312,252) | (349,868) | (139,463) | (170,651) | | 毛利 | 321,154 | 358,286 | 425,958 | 167,677 | 184,317 | | 其他收入 | 25.483 | 21,918 | 23,163 | 10,708 | 10,920 | | 預期信貸虧損模形下的減值 | | | | | | ...

截至6月30日，普源精电股东户数6124.00，较上期增加5.53%；人均流通股11087股，较上期减少 2.12%。2025年1月-6月，普源精电实现营业收入3.55亿元，同比增长15.57%；归母净利润1621.58万元， 同比增长112.10%。 分红方面，普源精电A股上市后累计派现2.55亿元。 机构持仓方面，截止2025年6月30日，普源精电十大流通股东中，易方达积极成长混合（110005）位居 第二大流通股东，持股285.26万股，为新进股东。富国天惠成长混合(LOF)A/B（161005）位居第三大流 通股东，持股228.87万股，为新进股东。易方达战略新兴产业股票A（010391）位居第七大流通股东， 持股119.92万股，为新进股东。富国新活力灵活配置混合A（004604）位居第八大流通股东，持股99.60 万股，为新进股东。金信深圳成长混合A（002863）位居第十大流通股东，持股79.68万股，为新进股 东。景顺长城成长龙头一年持有期混合A类（011058）、景顺长城电子信息产业股票A类（010003）、 景顺长城优选混合（260101）、景顺长城创新成长混合（006435）退出十大流通 ...

同惠电子 20250912 同惠电子业务分为元件参数测试仪器（占比近 45%）、安规线材测试仪 器、微弱信号检测仪、电力电子产品和系统集成测试设备五大板块。系 统集成测试设备增速快，体现公司向综合解决方案提供商转型方向。 公司关键器件国产化程度高，降低进口依赖和关税影响。2024 年毛利 率达 57.69%，净利率提升至 29.14%。2024 年营收接近 2 亿元，今 年上半年营收 1 亿元，显示良好增长势头，负债率仅 11%，财务结构稳 健，并坚持高比例分红。 中国电子测量仪器市场规模预计将从 2020 年的 48 亿美元增至 2025 年 的 66 亿美元，复合年均增长率（CAGR）为 6.54%，高于全球市场同 期预测增速。同惠电子募投项目结项后将形成 65,000 台各类仪器产能， 为未来业绩提升提供支持。 取得关键突破，如 TH521 系列半导体参数分析仪，将成为 2025 年下半年业 绩的重要增长点。同时，公司加快海外扩张步伐，德国子公司即将设立完成， 开拓欧洲市场。 同惠电子在产品创新和市场拓展方面有哪些具体举措？ 同惠电子在产品创新和市场拓展方面采取了多项举措。首先，公司推出了 TH521 ...

Core Viewpoint - Puyuan Precision Electric has shown significant growth in revenue and net profit, indicating strong operational performance and increasing investor interest in the company [2][3]. Financial Performance - For the first half of 2025, Puyuan Precision Electric achieved operating revenue of 355 million yuan, representing a year-on-year increase of 15.57% [2]. - The net profit attributable to shareholders reached 16.22 million yuan, marking a substantial year-on-year growth of 112.10% [2]. - Cumulative cash dividends since the company's A-share listing amount to 255 million yuan [2]. Stock Market Activity - On August 28, Puyuan Precision Electric's stock price increased by 3.34%, with a trading volume of 285 million yuan [1]. - The company recorded a financing buy-in amount of 21.41 million yuan and a net financing buy of 3.15 million yuan on the same day [1]. - As of August 28, the total margin trading balance was 110 million yuan, accounting for 4.16% of the circulating market value, indicating a high level of investor engagement [1]. Shareholder Composition - As of June 30, 2025, the number of shareholders increased to 6,124, a rise of 5.53% from the previous period [2]. - The average circulating shares per shareholder decreased by 2.12% to 11,087 shares [2]. - New institutional shareholders include E Fund Active Growth Mixed Fund and others, indicating growing institutional interest in the company [3].